BioCryst Pharmaceuticals shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $24M | 3.1M | 7.59 |
| 2025-06-30 | $32M | 3.6M | 8.96 |
| 2025-03-31 | $106k | 14k | 7.50 |
| 2024-12-31 | $106k | 14k | 7.52 |
| 2024-09-30 | $107k | 14k | 7.60 |
| 2024-06-30 | $401k | 65k | 6.18 |
| 2024-03-31 | $2.0M | 387k | 5.08 |
| 2023-12-31 | $3.2M | 529k | 5.99 |
| 2023-09-30 | $7.9M | 1.1M | 7.08 |
| 2023-06-30 | $38M | 5.3M | 7.04 |
| 2023-03-31 | $41M | 5.0M | 8.34 |
| 2022-12-31 | $30M | 2.6M | 11.48 |
| 2022-09-30 | $33M | 2.6M | 12.60 |
| 2022-06-30 | $34M | 3.2M | 10.58 |
| 2022-03-31 | $1.2M | 71k | 16.26 |
| 2021-12-31 | $183k | 13k | 13.83 |
| 2021-09-30 | $965k | 67k | 14.38 |
| 2021-06-30 | $12M | 755k | 15.81 |
| 2021-03-31 | $452k | 45k | 10.16 |
| 2020-06-30 | $1.4M | 303k | 4.77 |
| 2019-12-31 | $258k | 75k | 3.45 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management